Interleukin-10 producing-B cells and their association with responsiveness to rituximab in myasthenia gravis.
about
Inebilizumab, a B Cell-Depleting Anti-CD19 Antibody for the Treatment of Autoimmune Neurological Diseases: Insights from Preclinical StudiesRole of regulatory b cells in neuroimmunologic disordersCD1d(hi)CD5+ B cells expanded by GM-CSF in vivo suppress experimental autoimmune myasthenia gravis.T follicular helper cells and regulatory B cells dynamics in systemic lupus erythematosus.Characterization of B cells in muscle-specific kinase antibody myasthenia gravis.Peripheral CD5+ B cells in antineutrophil cytoplasmic antibody-associated vasculitis.A Lower Proportion of Regulatory B Cells in Patients with Henoch-Schoenlein Purpura NephritisCurrent Treatment, Emerging Translational Therapies, and New Therapeutic Targets for Autoimmune Myasthenia Gravis.Rituximab therapy in pemphigus and other autoantibody-mediated diseases.B10 Cell Frequencies and Suppressive Capacity in Myasthenia Gravis Are Associated with Disease Severity.Vitamin D effects on B cell function in autoimmunity.Efficacy and safety of rituximab for myasthenia gravis: a systematic review and meta-analysis.The dual nature of interleukin-10 in pemphigus vulgaris.B cells and progressive multifocal leukoencephalopathy: search for the missing linkOvercoming challenges in the diagnosis and treatment of myasthenia gravis.Illuminating vitamin D effects on B cells--the multiple sclerosis perspective.Potential importance of B cells in aging and aging-associated neurodegenerative diseases.Rituximab treatment of myasthenia gravis: A systematic review.Regulatory B10 cells display an altered homoeostasis in acute graft-versus-host disease.CD19+ Tim-1+ B cells are decreased and negatively correlated with disease severity in Myasthenia Gravis patients.A higher frequency of IL-10-producing B cells in Hepatitis B virus-associated membranous nephropathy.Autoimmune Thyroiditis and Myasthenia Gravis.Regulatory B Cells in Seropositive Myasthenia Gravis versus Healthy Controls.Significance of B10 cell in patients with thymoma complicated with myasthenia gravis.Myasthenia gravis with antibodies to MuSK: an update.B cells in the pathophysiology of myasthenia gravis.The Regulatory B Cell Compartment Expands Transiently During Childhood and Is Contracted in Children With Autoimmunity.B cells produce less IL-10, IL-6 and TNF-α in myasthenia gravis.Targeting B Cells and Plasma Cells in Autoimmune Diseases.Vitamin D: Effect on Haematopoiesis and Immune System and Clinical Applications
P2860
Q28067334-D84F455D-EC41-4EA2-B8D5-23C1F1231F29Q28077219-E6644AF5-8DE5-4435-92CB-6CFF5A9E8CFBQ34204228-A88FDFCB-7049-43E2-9297-7C9D76594710Q35097391-24575E56-EABE-44AA-85D4-8144028DAAD8Q35134860-03BF01D5-9FE5-4F1F-B71D-49F772F9FD6BQ35835724-1ADE5672-2264-4439-AD9F-4CED8CAB9699Q35974823-96E86583-6857-41AB-8A85-7BC0D204C59BQ36484383-DC2B1508-4845-4F29-98C8-9771E8409D6CQ37620483-BB46C97B-9E86-4E52-9864-98EC42D906E1Q37634710-5EA9CADB-2DAB-4DDD-84B0-6A3B9AFEBF2EQ38206792-3161AC36-C9CD-4B1E-ADA7-5B72D2522A99Q38259495-3BE28FBE-3473-44B1-9846-3380199C1A2DQ38281273-652301AC-E4F6-46F3-A924-CA0F9EBB0740Q38515349-6C622C8B-70D8-418B-933E-6304ED9A3318Q38671442-448F330F-4E9C-48AF-B169-72213F3B93D6Q38682352-A5F7A807-84CE-4A7F-89CB-7BE908A63184Q39084950-0B98B8D0-7697-4EAE-B205-3B1135946765Q39121466-96DFAAD4-A190-4656-A70C-8C3A11560F72Q39311644-7E214769-D756-44CC-9192-4E134869DBACQ39345723-05D3CA03-C8CD-487F-BA63-4CDCF37F8A60Q40812485-700C162F-ED7B-4F85-BA24-E214BDB96D6EQ40999568-90DE74DF-B107-49AD-9BED-EE8EADD73B1DQ41980478-4A587FED-4502-48FB-A1FB-5E5E31A13CA8Q44124678-F6209ACE-0A27-4780-AF96-7821B6FC6959Q47674286-C6A19E97-F105-4888-AAE0-E8127F209FAFQ47756482-49B9AAA0-CE23-44D3-8E0A-AECD460D0780Q50333756-00775EE9-254C-4121-B097-0E623404F2C6Q50763118-665A1365-C104-4998-8814-A464F4365538Q55234556-EEEB5BE2-554B-4DCD-8F5B-B36DB5C282C5Q58757535-73573C77-83E8-41AC-A949-3E41E0662D85
P2860
Interleukin-10 producing-B cells and their association with responsiveness to rituximab in myasthenia gravis.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Interleukin-10 producing-B cel ...... ituximab in myasthenia gravis.
@en
Interleukin-10 producing-B cel ...... ituximab in myasthenia gravis.
@nl
type
label
Interleukin-10 producing-B cel ...... ituximab in myasthenia gravis.
@en
Interleukin-10 producing-B cel ...... ituximab in myasthenia gravis.
@nl
prefLabel
Interleukin-10 producing-B cel ...... ituximab in myasthenia gravis.
@en
Interleukin-10 producing-B cel ...... ituximab in myasthenia gravis.
@nl
P2093
P2860
P356
P1433
P1476
Interleukin-10 producing-B cel ...... rituximab in myasthenia gravis
@en
P2093
Fu-Dong Shi
Roberto Bomprezzi
Samuel Xiang-Yu Shi
P2860
P304
P356
10.1002/MUS.23951
P577
2014-02-27T00:00:00Z